Meizhong Jin

Meizhong Jin is an accomplished chemist with extensive experience in oncology and medicinal chemistry. Currently serving as Senior Director of Oncology Chemistry at AstraZeneca since May 2021, Meizhong previously held positions as Senior Director and Head of Chemistry at Arrakis Therapeutics and Senior Director and Head of Medicinal Chemistry at WARP DRIVE BIO, INC. Key achievements include leading teams that developed first-in-class Molecular Glue GTP-KRAS inhibitors and Androgen Receptor degraders for prostate cancer. Meizhong's educational background includes post-doctoral training at the University of Notre Dame and the University of Wisconsin-Madison, focusing on the total synthesis of marine natural products.